Spectrophotometric determination of Diclofenac Sodium in pure form and in the pharmaceutical preparations
Article Sidebar
Main Article Content
Abstract
A rapid, simple and sensitive method for the determination of Diclofenac sodium using sodium 1,2-naphthoquine- 4-sulfonate (NQS) as reagent in an alkaline medium (pH 11.9) to form an orange-colored product that was a maximum absorbance at 456 nm. Beer’s law is obeyed in the range (8-44 µg/mL), with molar absorptivity (6.965×103 L/mol.cm), correlation coefficient 0.9996, and the limit of detection (0.185 µg/mL). The method has been successfully applied to the determination of Diclofenac sodium in pharmaceutical preparations
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Matin, A. A. Farajzadeh, M. A. and Jouyban, A. I. L., Farmaco 60 (2005) 855.
2. Adeyeye, C. M.; Li, P.K. In Analytical Profiles of Drug Substances , Florey, K., editor; Academic Press: New York, (1990), vol. 19, p. 123.
3. L.G. Lala, P.M. D’ Mello and S. R. Naik, J. Pharm. and Biomed. Anal. 29 (2002) 539.
4. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. (1998); 316:343–5.
5. Conroy S, Peden V. Unlicensed and off label analgesic use in paediatric pain management. Paediatr Anaesth.(2001);11:431–6.
6. Eva G. et al. New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells .(2013); 8(7): e66987
7. Shinde, V.M.; Tendolkar, N.M.; Desai, B.S. Simultaneous determination of paracetamol and diclofenac sodium in pharmaceutical preparation by quantitative TLC. J. Planar Chromatogr.- Mod. TLC (1994), 7 (1), 50–53.
8. Sun, S.W.; Fabre, H. Practical approach for validating the TLC assay of an active ingredient in pharmaceutical formulation. J. Liq. Chromatogr. (1994), 17 (2), 433–445.
9. Chawla, J.L.; Sodhi, R.A.; Sane, R.T. Simultaneous determination of chlorzoxazone, paracetamol, and diclofenac sodium by different chromatographic techniques. Indian Drugs (1996), 33 (4), 171–178
10. Gaudiano, M.C.; Valvo, L.; Bertocchi, P.; Manna, L. RP-HPLC study of the degradation of diclofenac and piroxicam in the presence of hydroxyl radicals. J. Pharm. Biomed. Anal. (2003), 32 (1), 151–158.
11. Chawla, J.L.; Sodhi, R.A.; Sane, R.T. Simultaneous determination of chlorzoxazone, paracetamol, and diclofenac sodium by different chromatographic techniques. Indian Drugs (1996), 33 (4), 171–178
12. Miller, R.B. High-performance liquid-chromatographic determination of diclofenac in human plasma using automated column switching. J. Chromatogr., Biomed. Appl. (1993), 127 ((2) J. Chromatogr. 616), 283–290.
13. Kubala, T.; Gambhir, B.; Borst, S.I. Specific stability indicating highperformance liquid chromatography method to determine diclofenac sodium in raw materials and pharmaceutical solid dosage forms. Drug Dev. Ind. Pharm. (1993), 19 (7), 749–757.
14. Li, K.; Zhao, F.L.; Yuan, Y.S.; Tan, L. Determination of diclofenac sodium in human plasma by RP-HPLC. Yaowu Fenxi Zazhi (1995), 15 (5), 17–19.
15.Giagoudakis, G.; Markantonis, S.L. An alternative high-performance liquid-chromatographic method for the determination of diclofenac and flurbiprofen in plasma. J. Pharm. Biomed. Anal. (1998), 17 (4–5), 897–901.
16. Lala, L.; D’ Mello, P.M.; Naik, S.R. HPTLC determination of diclofenac sodium from serum. J. Pharm. Biomed. Anal. (2002), 29 (3), 539–544. 17.Hajkova,R.; Solich, P.; Pospisilova, M.; Sicha, J.; Anal. Chim. Acta (2002), 467, 91. 18. Carreira, L.A.; Rizk, M.; Elshabrawy, Y.; Zakhari, N.A.; Toubar, S.S.; J. Pharm. Biomed. Anal. (1995), 13,1331. 19. Arancibia, J.A.; Escandar, G.M; Analyst (1999), 124, 1833. 20. Pimenta, A. M.; Araújo, A. N.; Montenegro, M. C. B. S. M.; Anal. Chim. Acta (2002), 470, 185. 21. Damiani, P.C.; Bearzotti, M.; Cabezón, M.A.; Olivieri, A.C.; J. Pharm. Biomed. Anal. (1999), 20, 587.
22. Mathur, S.C.; Kumar, Y.; Prasad, P.B.N.; Rao, A.C.S.; Rathore, Y.K.S.; Gupta, S.C. A simple colorimetric estimation of diclofenac sodium in dosage forms. Indian Drugs (1994), 31 (9), 447–448.
23. Prado, M.S.A.; Steppe, M.; Tavares, M.F.M.; Kedor-Hackmann, E.R.M.; Santoro, M.I.R.M. Method validation for diclofenac sodium in pharmaceutical by capillary electrophoresis. J. Capillary Electrophor. (1999), 6 (3–4), 125–129. 24. Donato, M.G.; Baeyens, W.; Vandenbossche, W.; Sandra, P.; J. Pharm. Biomed. Anal. (1994), 12, 21. 25. Aurora-Prado, M.S.; Steppe, M.; Tavares, M.F.M.; Kedor - Hackmann, E.R.M.; Santoro, M.I.R.M.; J. AOAC Inter. (2002), 85, 333.
26. Tubino, M.; de Souza, R.L.; J. AOAC Inter. (2005), 88 in press.
27. Tubino, M.; de Souza, R.L.; Talanta, (2005), in press. 28. de Cordova, M.L.F.; Barrales, P.O.; Diaz, A.M.; Anal. Chim. Acta (1998), 369, 263.
29. Bucci, R.; Magri A. D.; Magri, A. L.; Fresen. J. Anal. Chem. (1998), 362, 577. 30. Agrawal, Y. K.; Upadyay, V. P.; Menon, S. K.; Indian J. Pharm. Sci. (1988), 50, 58. 31. Kamath, B.V.; Shivram, K.; Oza, G.P.; Vangani, S.; Anal. Lett. (1993), 26, 665. 32. Shivram, K.;Kamath, B.V.; Anal. Lett. (1993), 26, 903. 33. Botello, J.C.; Caballero, G.P.; Talanta (1995), 42, 105. 34. Sherif, Z. A. E.; Walash, M. I.; Tarras, M. F. E.; Osman, A. O.; Anal. Lett. (1997), 30, 1881. 35. Kramancheva, I.; Dobrev, I.; Brakalov, L.; Anal. Lett. (1997), 30, 2235. 36.Kustrin, S.A.; Zivanovic, L.; Radulovic, D.; Vasiljevic, M.; Analyst (1991), 116, 753. 37. Kustrin S. A.; Zivanovic, Lj.; Zecevic, M.; Radulovic, D.; J. Pharm. Biomed. Anal. (1997), 16, 147. 38. de Micalizzi, Y. C.; Pappano, N. B.; Debattista, N. B.; Talanta (1998), 47, 525.
39. El - Didamony, A.M.; Amin, A.S.; Anal. Lett. (2004), 37, 1151.
40.Darwish IA, et al. Spectrophotometric study for the reaction between fluvoxamine and 1,2-naphthoquinone-4-sulphonate: Kinetic, mechanism and use for determination of fluvoxamine in its dosage forms. Spectrochim Acta Part A (2009) 72: 897-902.
41. Li Q and Zhang H. A novel spectrophotometric method for the determination of aminophylline in pharmaceutical samples in the presence of methanol. Spectrochim Acta Part A (2008)70: 284-289.
42.Li QM and Yang ZJ. Spectrophotometric determination of aminomethylbenzoic acid using sodium 1,2-naphthoquinone-4-sulfonate as the chemical derivative chromogenic reagent. Spectrochim Acta (2007) 66: 656-661.
43. Job P: Advanced Physicochemical Experiments. 2 edition. Oliner and Boyd, Edinburgh; (1964), 54.